BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cloyd JM, Poultsides GA. The Landmark Series: Pancreatic Neuroendocrine Tumors. Ann Surg Oncol 2021;28:1039-49. [PMID: 32948965 DOI: 10.1245/s10434-020-09133-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng J, Pulvirenti A, Javed AA, Michelakos T, Paniccia A, Lee KK, Ferrone CR, Wei AC, He J, Zureikat AH; additional members of the Pancreatic Neuroendocrine Disease Alliance (PANDA). Minimally Invasive vs Open Pancreatectomy for Pancreatic Neuroendocrine Tumors: Multi-Institutional 10-Year Experience of 1,023 Patients. J Am Coll Surg 2022;235:315-30. [PMID: 35839409 DOI: 10.1097/XCS.0000000000000257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Xiao Y, Xu G, Cloyd JM, Du S, Mao Y, Pawlik TM. Predicting Novel Drug Candidates for Pancreatic Neuroendocrine Tumors via Gene Signature Comparison and Connectivity Mapping. J Gastrointest Surg 2022;26:1670-8. [PMID: 35508682 DOI: 10.1007/s11605-022-05337-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sirtl S, Mahajan UM, Auernhammer CJ, Dziadkiewicz P, Hohmann E, Wójcik M, Kos-Kudła B, Hartleb M, Knösel T, Schirra J, Mayerle J, Schulz C, Żorniak M. Impact of tumor size and location on endoscopic ultrasound-guided sampling of pancreatic neuroendocrine tumors: A recursive partitioning analysis. Pancreatology 2022;22:644-50. [PMID: 35589512 DOI: 10.1016/j.pan.2022.04.014] [Reference Citation Analysis]
4 Gupta V, Bhandare MS, Chaudhari V, Parray A, Shrikhande SV. Organ preserving pancreatic resections offer better long-term conservation of pancreatic function at the expense of high perioperative major morbidity: a fair trade-off for benign or low malignant potential pancreatic neoplasms-a single-center experience. Langenbecks Arch Surg 2022. [PMID: 35298681 DOI: 10.1007/s00423-022-02491-y] [Reference Citation Analysis]
5 Kaslow SR, Vitiello GA, Prendergast K, Hani L, Cohen SM, Wolfgang C, Berman RS, Lee AY, Correa-Gallego C. Surgical Treatment of Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: An NCDB Analysis. Ann Surg Oncol 2022. [PMID: 35246811 DOI: 10.1245/s10434-022-11477-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Addeo P, Cusumano C, Goichot B, Guerra M, Faitot F, Imperiale A, Bachellier P. Simultaneous Resection of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases: Safety and Oncological Efficacy. Cancers (Basel) 2022;14:727. [PMID: 35158996 DOI: 10.3390/cancers14030727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]